The only Global Contract Development and ManufacturingFacilities Database subscription that actively tracks over 400+dedicated CDMO facilities providing development andmanufacturing services for biopharmaceuticals.
Hundreds of facilities manufacturing clinical andcommercial scale biologics, account for $16.89 billionin services sales in 2023, growing at 17% annually.
Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updatedcontinually and includes comprehensive information and insights.
Top300Bio CDMO Facility Index ranks each ‘dedicated’ CDMO facility and providesregional quantitative analysis of biomanufacturing regions and clusters.
- Total bioreactor liter capacity
- CDMO/CMO service expertise
- Future Biomanufacturing capacity coming online
- Number of commercial and clinical biological products manufactured
- Revenue estimates
- Strengths and Challenges
- Technologies and expertise, and much more
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook